The Insurance Regulatory and Development Authority of India (IRDAI) has now allowed general and standalone health insurers to offer the
Read More
AstraZeneca reported successful results from its Phase III DAPA-CKD clinical trial of Farxiga (dapagliflozin) in end stage kidney disease (ESKD). The trial
Read More
Aarti Drugs Limited on Monday announced the financial results of the quarter ended June 2020. The company recorded consolidated quarterly revenue
Read More
Immunic, Inc., a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases,
Read More
Drug firm Unichem Laboratories NSE 2.05 % on Wednesday said it has received approval from the US health regulator for
Read More